MWNA
INBX

Marshall Wace North America’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Marshall Wace North America’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,992
Closed -$324K – 1734
2020
Q3 		$324K Buy
+17,992
New +$326K ﹤0.01% 1054

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Marshall Wace North America's INBX Position: Q4 2020 in Review

Marshall Wace North America sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2020, closing a stake of 17,992 shares — an estimated $324K sold.

Marshall Wace North America first reported a position in INBX in Q3 2020 and held it in 1 quarter. The position peaked at $324K in Q3 2020. 51 funds tracked by Wall St. Rank hold INBX as of Q4 2020.

  • Marshall Wace North America reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 17,992 Inhibrx, Inc. Common Stock shares in Q4 2020, an estimated $324K.
  • Marshall Wace North America first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Marshall Wace North America's Inhibrx, Inc. Common Stock position peaked at $324K in Q3 2020.
  • 51 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.